 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
STRATEGY Proxima Therapeutics is pioneering a new technique to prolong the life of patients with malignant brain tumors and sought the expertise and professionalism of Eclipse Product Development to design and develop the GliaSite infuser. We utilized ID and Mechanical Engineering expertise to develop a radiation protective syringe shield, which protects the user from harmful radiation being used in this new therapy. |
|
SUCCESS Eclipse Product Development followed stringent FDA controls to help the GliaSite pass 510-K approval. |
 |
|
For more information visit:
proximatherapeutics.com |
 |
